M.D., Ph.D., MBA, President & Co-founder CEO, Combined Therapeutics Inc.
Medical doctor, entrepreneur and affiliated to six famous universities (Massachusetts Institute of Technology in US, London School of Economics in UK, Paris VI, Paris V, Paris Dauphine in France and Hult international Business School in UK). Romain is currently President and co-founder CEO of Combined Therapeutics Inc, a nanomedicine startup based in US (Cambridge) and UK (London). CTx is converging nanomedicine and biotechnology to enhance the tumoral cells destruction and the tumoral microenvironment modification. After having set-up the first reference center for primary immunodeficiency in France in 2005, Romain joined Institut Mérieux group in 2008. He holds several positions accross the group: ABlinc (USA), Shantha Biotechnics (India), Transgene (China and France).
Emerging Therapeutics Showcase: Combined Therapeutics Inc.
CTx is converging nanomedicine and biotechnology to enhance the tumoral cells destruction and the tumoral microenvironment modification.
New Generation of Therapeutic and Intelligent mRNA
CTx is developing a new generation of therapeutic and intelligent mRNA (IV injection) which allow to improve local immunotherapy. CTx is launching a platform to treat the diseased cells in combination with virotherapy (and others…).